SG43249A1 - Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture - Google Patents

Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture

Info

Publication number
SG43249A1
SG43249A1 SG1996006425A SG1996006425A SG43249A1 SG 43249 A1 SG43249 A1 SG 43249A1 SG 1996006425 A SG1996006425 A SG 1996006425A SG 1996006425 A SG1996006425 A SG 1996006425A SG 43249 A1 SG43249 A1 SG 43249A1
Authority
SG
Singapore
Prior art keywords
asmatic
pyrazinones
manufacture
processes
action
Prior art date
Application number
SG1996006425A
Other languages
English (en)
Inventor
Bernhard Dr Kutscher
Norbert Dr Hofgen
Thomas Dr Buchner
Ute Dr Achterrath-Tuckermann
Stefan Professor Dr Szelenyi
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of SG43249A1 publication Critical patent/SG43249A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1996006425A 1995-03-24 1996-03-21 Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture SG43249A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510965A DE19510965A1 (de) 1995-03-24 1995-03-24 Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
SG43249A1 true SG43249A1 (en) 1997-10-17

Family

ID=7757727

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006425A SG43249A1 (en) 1995-03-24 1996-03-21 Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture

Country Status (30)

Country Link
US (1) US5723463A (pt)
EP (1) EP0736532B1 (pt)
JP (1) JP4124280B2 (pt)
KR (1) KR100401395B1 (pt)
CN (1) CN1058968C (pt)
AR (1) AR002039A1 (pt)
AT (1) ATE217624T1 (pt)
AU (1) AU697908B2 (pt)
BR (1) BR9601093A (pt)
CA (1) CA2172472C (pt)
CZ (1) CZ290784B6 (pt)
DE (2) DE19510965A1 (pt)
DK (1) DK0736532T3 (pt)
ES (1) ES2174989T3 (pt)
HR (1) HRP960129B1 (pt)
HU (1) HUP9600731A3 (pt)
IL (1) IL117621A (pt)
MX (1) MX9601069A (pt)
NO (1) NO307091B1 (pt)
NZ (1) NZ286232A (pt)
PL (1) PL184800B1 (pt)
PT (1) PT736532E (pt)
RU (1) RU2143433C1 (pt)
SG (1) SG43249A1 (pt)
SI (1) SI0736532T1 (pt)
SK (1) SK36596A3 (pt)
TR (1) TR199600217A2 (pt)
TW (1) TW426682B (pt)
UA (1) UA45319C2 (pt)
ZA (1) ZA962270B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200100792A1 (ru) * 1999-01-20 2002-10-31 Арцнаймиттельверк Дрезден Гмбх Применение имидазо[1,5-a]-пиридо[3,2-e]-пиразинонов в качестве лекарственных средств
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
AU2008297876B2 (en) 2007-09-14 2011-07-07 Addex Pharma S.A. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
CN101801930B (zh) * 2007-09-14 2013-01-30 奥梅-杨森制药有限公司 1,3-二取代的-4-苯基-1h-吡啶-2-酮
ES2637794T3 (es) * 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
AU2008329072A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-A) pyrazines as inhibitors of phosphodiesterase 10
CA2706866A1 (en) 2007-11-30 2009-06-04 Biotie Therapies Gmbh Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
KR102461134B1 (ko) 2014-01-21 2022-10-28 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166344A (en) * 1989-05-31 1992-11-24 Berlex Laboratories, Inc. Process for the preparation of imidazoquinoxalinones
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
KR100207360B1 (ko) * 1991-06-14 1999-07-15 돈 더블유. 슈미츠 이미다조[1,5,-a]퀸옥살린
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
JP3252484B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ４，５−ジヒドロ［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体の製造方法
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ３環性トリアゾロ誘導体の製造方法
DE4329970A1 (de) * 1993-03-31 1994-10-06 Basf Ag Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
FR2704547B1 (fr) * 1993-04-30 1995-06-09 Adir Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994026746A1 (en) * 1993-05-06 1994-11-24 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE
CA2112290C (en) * 1993-12-23 2004-06-01 John R. Francis A clock recovery circuit for serial digital video
JP3240462B2 (ja) * 1996-05-24 2001-12-17 株式会社ケンウッド 光ディスク装置の光ピックアップサーボ装置

Also Published As

Publication number Publication date
AU4825796A (en) 1996-10-03
IL117621A (en) 1999-05-09
NO961173D0 (no) 1996-03-22
EP0736532B1 (de) 2002-05-15
AU697908B2 (en) 1998-10-22
ES2174989T3 (es) 2002-11-16
JPH08269059A (ja) 1996-10-15
DE59609201D1 (de) 2002-06-20
KR960034204A (ko) 1996-10-22
KR100401395B1 (ko) 2003-12-24
CZ74796A3 (en) 1996-10-16
CA2172472A1 (en) 1996-09-25
JP4124280B2 (ja) 2008-07-23
ATE217624T1 (de) 2002-06-15
EP0736532A1 (de) 1996-10-09
PT736532E (pt) 2002-10-31
CN1058968C (zh) 2000-11-29
NO961173L (no) 1996-09-25
US5723463A (en) 1998-03-03
CN1140173A (zh) 1997-01-15
SK36596A3 (en) 1997-02-05
AR002039A1 (es) 1998-01-07
HRP960129A2 (en) 1997-08-31
DE19510965A1 (de) 1996-09-26
HUP9600731A3 (en) 1997-04-28
HRP960129B1 (en) 2002-12-31
CZ290784B6 (cs) 2002-10-16
HUP9600731A2 (en) 1997-01-28
IL117621A0 (en) 1996-07-23
PL313434A1 (en) 1996-09-30
TW426682B (en) 2001-03-21
ZA962270B (en) 1996-09-30
BR9601093A (pt) 1998-01-06
CA2172472C (en) 2000-01-18
DK0736532T3 (da) 2002-09-02
NZ286232A (en) 1996-10-28
HU9600731D0 (en) 1996-05-28
NO307091B1 (no) 2000-02-07
TR199600217A2 (tr) 1996-10-21
SI0736532T1 (en) 2002-08-31
RU2143433C1 (ru) 1999-12-27
UA45319C2 (uk) 2002-04-15
MX9601069A (es) 1997-02-28
PL184800B1 (pl) 2002-12-31

Similar Documents

Publication Publication Date Title
SG43249A1 (en) Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture
PL326841A1 (en) Poly (9,9'-spirodiffluorenes), their production and application
HU9501600D0 (en) Thieno[1,5]benzodiazepine use
ZA942570B (en) 1,5 benzodiazepine derivatives
ZA972134B (en) Benzoxazepine compounds their production and use
HUP9900339A2 (hu) Vízben oldódó kopolimerek, eljárás az előállításukra, valamint alkalmazásuk
SG52950A1 (en) Process for producing polyacetal copolymer
AU6016896A (en) Heterocyclic compounds, their production and use
AP9400657A0 (en) 1,5 benzodiazepine derivatives
AU6039394A (en) Process for making 1,3-diols and 3-hydroxyaldehydes
ZA972831B (en) Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives.
EP0761711A3 (en) Thermoplastic copolymer based on polyvinyl alcohol, process for its production and use
ZA966757B (en) Novel compounds and process.
NZ326039A (en) Process for making 3,4-dihydro-pyrimidin-2(1h)-one derivatives
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
HUP9801716A3 (en) 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, ph
HU9601918D0 (en) N,n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
IL113150A0 (en) 1,2,4-triazolo [4,3-a]pyrazin-4-one derivatives and preparation thereof
HUP9700628A3 (en) 4-thia-1-aza-bicyclo[3.2.0]heptan-3-imino-2-izopropiliden-7-oxo-beta-lactame derivatives, process for producing them and use of them
EP0778278B1 (de) Alkoxyformoxysilane, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
AU8701298A (en) 2,3-dihydro-benzofuranol derivatives and process for resolving the same
IL133533A0 (en) Non-immunosuppressive compounds, process for their preparation and different uses thereof
AU685960C (en) Solid solutions of pyrrolo-{3,4-c}-pyrroles with quinacridonequinones
ZA965883B (en) N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
AU2840095A (en) Solid solutions of pyrrolo-{3,4-c}-pyrroles with quinacridonequinones